# Takeda Ventures: portfolio, investments and team > Takeda Ventures is a corporate vc based in United States. 13 investments on record, latest Nov 2019. Portfolio, stages, co-investors and team. Source: https://millionrounds.com/fund/takeda-ventures (Millionrounds; every figure on the page links to its filing or article) United States · [Investor](https://millionrounds.com/investors) # Takeda Ventures Last cheque observed Nov 2019. Silence since then is not evidence of inactivity: our sources miss unannounced rounds. Quiet Corporate VC Growth Seed Series A Electronics Software Aggregator Cheques on record **0%** of best year **0** **cheques in 12 months**, 13 on record Since the last cheque **2539** days **00** hrs **00** min **00** sec Median round **$8.3M** Rounds led **1 of 13** Sole investor **1 rounds** Exits **3 from the portfolio** Mostly in **United States, 58%** Pitch Takeda Ventures ## Takeda Ventures highlights - 01 13 rounds on record - 02 Mostly Series A and Series B: 73% of its rounds - 03 Sole investor in 1 rounds, median undisclosed - 04 3 exits from the portfolio ## What they do - **Type:** Corporate VC (from a list, unverified) - **Cheque size:** Not stated - **Stages:** Growth Seed Series A Series B - **Sectors:** Electronics Software Aggregator - **Based in:** Cambridge, United States - **Cold pitches:** Not stated ## The record Every round we can evidence, newest first **13 appearances** - **2019** 1 round - **Nov** **ProteKt Therapeutics** IL · FinSMEs **$3.6M** With 6 others - **2016** 1 round - **Aug** **[Bioniz Therapeutics](https://millionrounds.com/company/bioniz-therapeutics)** Series A · US · Socaltech **$13M** *Led* - **2013** 2 rounds - **Nov** **[Hookipa Biotech](https://millionrounds.com/company/hookipa-biotech)** Series B · AT · finsmes.com **$26M** With 4 others - **Jun** **[Heptares Therapeutics](https://millionrounds.com/company/heptares-therapeutics)** Series B · GB · finsmes.com **$21M** With 2 others - **2012** 2 rounds - **Nov** **[ArmaGen Technologies](https://millionrounds.com/company/armagen-technologies)** Series A · US · prnewswire.com **$17M** With 3 others - **Jul** **[Juventas Therapeutics](https://millionrounds.com/company/juventas-therapeutics)** Series B · US · finsmes.com **$22M** With 7 others - **2011** 2 rounds - **Jun** **[Redwood Bioscience](https://millionrounds.com/company/redwood-bioscience)** US · redwoodbioscience.com **Undisclosed** Sole investor - **May** **[Naurex](https://millionrounds.com/company/naurex)** Series A · US · fiercebiotech.com **$18M** With 5 others - **2007** 1 round - **Jun** **[Serenex](https://millionrounds.com/company/serenex)** Series D · US **$26M** With 9 others - **2006** 2 rounds - **Feb** **[Lectus Therapeutics](https://millionrounds.com/company/lectus-therapeutics)** Series A · GB · lectustherapeutics.com **$14M** With 3 others - **Jan** **[Symphogen](https://millionrounds.com/company/symphogen)** Series D · DK · bulletin.sciencebusiness.net **$25M** With 7 others - **2005** 2 rounds - **Oct** **[Serenex](https://millionrounds.com/company/serenex)** Series C · US **$30M** With 5 others - **Apr** **[Receptor Biologix](https://millionrounds.com/company/receptor-biologix)** Series A **$34M** With 5 others An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor. ## The team We hold **5** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them. ## Exits from the portfolio Companies it backed that were later bought or listed **3 in all** **[Naurex](https://millionrounds.com/company/naurex)** Bought by [Allergan](https://millionrounds.com/fund/allergan) **$560M** Jul 2015 **[Heptares Therapeutics](https://millionrounds.com/company/heptares-therapeutics)** Bought by Sosei **Undisclosed** Feb 2015 **[Serenex](https://millionrounds.com/company/serenex)** Bought by [Pfizer](https://millionrounds.com/fund/pfizer) **Undisclosed** Mar 2008 An exit counts when it came after the firm's first round in the company. From historical deal records. ## The cheque Growth Seed Series A Median round joined **$8.3M** the round, not its cheque Alone, median **-** Led 1 of 13 rounds **8%** - **Sole investor:** 1 rounds - **Last cheque:** Nov 2019 - **Exits:** 3 from the portfolio Rounds by stage said on their site - Series A said *5* - Series B said *3* - Series D *2* - Series C *1* - Growth said *-* - Seed said *-* Cheques by year Led Joined 2005 2019 Often in the room with - [Boehringer Ingelheim Venture Fund](https://millionrounds.com/fund/boehringer-ingelheim-venture-fund) 2 - [Essex Woodlands Healthcare Partners](https://millionrounds.com/fund/essex-woodlands-health-ventures) 2 - [Intersouth Partners](https://millionrounds.com/fund/intersouth-partners) 2 - [Lilly Ventures](https://millionrounds.com/fund/lilly-ventures-2) 2 - [Mediphase Venture Partners](https://millionrounds.com/fund/mediphase-venture-partners) 2 - [Ritchie Capital Management](https://millionrounds.com/fund/ritchie-capital-management) 2 **Pitching Takeda Ventures?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque. Add to your CRM *→* ## Who they invest alongside The investors most often in the same rounds as Takeda Ventures. A count of rooms they were both in, not a relationship either has claimed. [**Boehringer Ingelheim Venture Fund** Corporate VC **2** rounds together](https://millionrounds.com/fund/boehringer-ingelheim-venture-fund)[**Essex Woodlands Healthcare Partners** VC firm **2** rounds together](https://millionrounds.com/fund/essex-woodlands-health-ventures)[**Intersouth Partners** VC firm **2** rounds together](https://millionrounds.com/fund/intersouth-partners)[**Lilly Ventures** Growth equity **2** rounds together](https://millionrounds.com/fund/lilly-ventures-2)[**Mediphase Venture Partners** VC firm **2** rounds together](https://millionrounds.com/fund/mediphase-venture-partners)[**Ritchie Capital Management** VC firm **2** rounds together](https://millionrounds.com/fund/ritchie-capital-management)[**Seaflower Ventures** VC firm **2** rounds together](https://millionrounds.com/fund/seaflower-ventures)[**Sofinnova Partners** VC firm **2** rounds together](https://millionrounds.com/fund/sofinnova-partners) ## Quick answers about Takeda Ventures ### What does Takeda Ventures invest in? Takeda Ventures invests most often at Series A and Series B (73% of the rounds on record), in sectors such as Electronics, Software and Aggregator. ### How active is Takeda Ventures? 13 investments on record, 0 of them in the last 12 months, and it led 1. The most recent was in Nov 2019. ### What has Takeda Ventures invested in recently? Its most recent investments on record: ProteKt Therapeutics (Undisclosed round, Nov 2019) and Bioniz Therapeutics (Series A, Aug 2016). ### How big are Takeda Ventures's cheques? The median round it joins is $8.3M. ### Does Takeda Ventures lead rounds? Sometimes: it led 1 of its 13 investments on record (8%). ### Where does Takeda Ventures invest? Most of the companies it backs are in the United States (58%), the United Kingdom (17%) and Israel (8%). ### Is Takeda Ventures investing now? No investments in the last 12 months; the latest was in Nov 2019. ### Who does Takeda Ventures invest alongside? Most often Boehringer Ingelheim Venture Fund (2 rounds together), Essex Woodlands Healthcare Partners (2 rounds together) and Intersouth Partners (2 rounds together). ## Raising now? Find the investors who back rounds like yours, and keep every conversation on one fundraising board. Find similar investorsOpen your CRM Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=takeda-ventures) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=takeda-ventures)